Pythium insidiosum is an aquatic oomycete that causes pythiosis, an important and severe disease of difficult treatment that affects humans, domestic and wild animals. This infection is often described in horses in Brazil and humans in Thailand. In clinical practice, we have observed many cases that do not respond to available therapies, indicating the need to explore alternative therapeutic approaches. In this sense, studies using metal compounds in conjunction with available antimicrobial agents have been demonstrated greater antimicrobial activity. Thus, in this research, we tested in vitro activities of metallic compounds containing cadmium, lead, copper, manganese, or zinc against 23 isolates of P. insidiosum. The assays were performed by broth microdilution based on CLSI M38-A2 document. The minimum inhibitory and fungicidal concentrations were established for all isolates. Copper acetate and cadmium acetate showed the highest inhibitory effects, with minimal inhibitory concentration ranging from 4-64 μg/ml and 16-256 μg/ml, respectively. The mean geometric for minimal fungicidal concentrations were, respectively, 26 μg/ml and 111.43 μg/ml for copper acetate and cadmium acetate. These results suggest that copper and cadmium can inhibit P. insidiosum growth, highlighting the greater inhibitory activity of copper acetate. In addition, our results propose that copper and/or C The Author 2016. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com
Introduction
Pythiosis is a relevant disease caused by the aquatic oomycete Pythium insidiosum. 1 The infection has been described to affect horses in Brazil in marshy regions such as the Pantanal Mato-Grossense and Rio Grande do Sul State. 2, 3 In human beings, a large number of cases of pythiosis has been reported in Thailand. 4 The therapies commonly used to treat pythiosis include surgery, chemotherapy, and immunotherapy, either alone or in combination. [5] [6] [7] [8] However, in clinical practice, we have observed many cases that do not respond to these therapies, demonstrating the need to research alternative therapeutic approaches. In this sense, studies employing metal compounds in combination with antimicrobial agents have been explored as a promising alternative. Antimicrobials complexed with metal compounds exhibit greater activity than free drugs. 9 This study aimed to evaluate in vitro susceptibility of P. insidiosum to metal compounds containing cadmium, lead, copper, manganese, and zinc.
Materials and methods

Pythium insidiosum isolates and inoculum preparation
Twenty-one Brazilian clinical isolates of P. insidiosum obtained from horses with pythiosis and two standard strains (ATCC 58637 and CBS 101555) were used in this study. The microorganisms were isolated from infected tissues of animals, and the cultures were maintained in Corn Meal Agar (CMA) at 37
• C. All clinical isolates were previously identified by morphological analysis, as well as polymerase chain reaction (PCR) and DNA sequencing of Internal Transcribed Spacer region of ribosomal DNA (ITS region). All inocula used for susceptibility testing were prepared as described by Pereira et al. 
Metallic compounds and in vitro susceptibility test
In this experiment, broth microdilution methodology based on the Clinical and Laboratory Standards Institute M38-A2 document 10 adapted by Pereira et al. 5 was used. Compounds containing cadmium acetate, lead acetate, copper acetate, manganese acetate, zinc acetate, and zinc sulfate were commercially obtained. The compounds were diluted in Milli-Q water to perform the stock solutions. From these solutions, serial dilutions were performed in RPMI medium, and the tested concentrations ranged from 0.5 μg/ml to 256 μg/ml. In each microdilution plate well, 100 μl of each metallic compound dilution was added to an equal volume of inoculum. A positive control (100 μl RPMI plus 100 μl inoculum) and a negative control (100 μl RPMI plus 100 μl metallic compound dilution) were prepared for all samples. All tests were performed in triplicate. The results were read after 48 h of incubation, and the visual presence or absence of hyphae was observed. The lowest metallic compound concentration capable of inhibiting microorganism growth in the positive sample was considered the minimal inhibitory concentration (MIC). The minimum fungicidal concentration (MFC) was determined by transferring 0.1 ml of a metallic compound at a concentration equal to or higher than the MIC standard to test tubes containing 0.9 ml Sabouraud broth. After a 96 h incubation period at 37 o C, the lowest metallic compound concentration that did not exhibit growth was considered the MFC.
Results
The results of in vitro susceptibility of P. insidiosum isolates tested are demonstrated in Table 1 .
Copper acetate showed a greater inhibitory effect against isolates of P. insidiosum, with MIC ranging from 4 to 64 μg/ml. Additionally, the MIC 50 and MIC 90 values were 8 and 64 μg/ml, respectively. The other metallic compound with inhibitory activity against P. insidiosum isolates was cadmium acetate. For this compound, MIC ranged from 16 to 256 μg/ml, and the MIC 50 and MIC 90 values were 128 and 256 μg/ml, respectively.
We observed that the compounds lead acetate, manganese acetate, zinc acetate, and zinc sulfate were not able to inhibit P. insidiosum isolates at the tested concentrations. This is the first study to evaluate the antimicrobial activity of metallic compounds of copper, cadmium, lead, manganese, and zinc against P. insidiosum.
Discussion
The search for new therapeutic approaches is encouraged by the reduced susceptibility of P. insidiosum to available drugs because this oomycete has no ergosterol, the component target of most available antifungals, 7 in its cytoplasmic membrane. Infections caused by P. insidiosum respond poorly to chemotherapy, requiring the use of immunotherapy or surgical excision and, in many cases, a combination of more than one therapeutic method. 6 In this regard, complexing metallic compounds to antimicrobials appears to be a promising alternative for the treatment of infections resistant to the available drug armamentarium. 9 This study showed that compounds containing copper and cadmium were able to inhibit in vitro growth of P. insidiosum, with MIC ranging from 4 to 64 μg/ml and 16 to 256 μg/ml and with MFC of 4 to 256 μg/ml and 16 to >256 μg/ml, respectively. The use of metallic compounds alone is hazardous due to toxicity for the hosts. In order to reduce the toxicity and increase the activity against the microorganisms many studies have been conducted mainly with complexes of copper and antimicrobials against bacteria 11, 12 and fungi. 13, 14 Devereux et al. 15 observed a significant increase in therapeutic potential against Candida albicans when thiabendazole was complexed with copper. Copper complexes of thiosemicarbazones have been tested against the human pathogenic fungi Aspergillus niger and Paecilomyces variotii. 16 Similarly, Mendes et al. 17 complexed copper with thiosemicarbazone, revealing a significant reduction in the MIC against C. albicans.
Zabrieski et al. 18 tested nanoparticle formulations containing copper oxide and zinc oxide against Pythium ultimum and Pythium aphanidermatum. These authors showed that the copper-containing formulation demonstrated greater inhibition of the growth of oomycetes, whereas the formulation containing zinc showed only a fungistatic effect. The results observed for copper in the present study were similar to those reported by Zabrieski et al. 18 The authors suggest that the siderophores secreted by P. ultimum and P. aphanidermatum to capture iron form complexes with copper. This process causes a disruption in the iron homeostasis of the microorganism. Zanette et al. 19 demonstrated the importance of iron in the pathophysiology of infections caused by P. insidiosum. The possible interference of iron metabolism by copper represents a probable copper toxicity mechanism. However, additional studies must be performed to assess this hypothesis. In this study, cadmium inhibited P. insidiosum growth; however, it is a toxic metal that bioaccumulates in plants and animal tissues. Furthermore, Riemschneider et al. 20 reported that the cadmium in subtoxic doses has immunosuppressive effect that would be undesirable for its use in clinical practice. However, more pharmacological and bioassay studies should be conducted in order to verify the safe clinical applications of this metal. The results of this study and of previous reports allow us to consider the possibility of developing different antimicrobial agents complexed to metallic compounds as a therapeutic alternative for the treatment of diseases caused by microorganisms that exhibit low susceptibility to available drugs. In addition, we suggest the use of copper and/or cadmium in the development of new formulations with antimicrobial activity against P. insidiosum. Further studies are required to evaluate the potential of these new complexed formulations against P. insidiosum in experimental models in vitro and in vivo.
